학술논문

LBA40 Phase II study of multiple LXH254 drug combinations in patients (pts) with unresectable/metastatic, BRAF V600- or NRAS-mutant melanoma
Document Type
Abstract
Source
In Annals of Oncology September 2022 33 Supplement 7:S1407-S1407
Subject
Language
ISSN
0923-7534